Buprenorphine Prescribing Flexibility: Buprenorphine Monoproduct for Adverse Effects from Buprenorphine/Naloxone Guidance

Credit Available: CE Credit(s): No
Certificate: No

Is it appropriate to prescribe buprenorphine monoproduct on a case-by-case basis for the treatment of Opioid Use Disorder for management of patients who experience adverse effects from buprenorphine/naloxone (bup/nx; Suboxone, Zubsolv)?

Kenneth Stoller, MD, 2018 Steering Committee Meeting

Didn't find what you were looking for?